| Literature DB >> 26089619 |
Mohammad Abdi1, Mohammad Said Hakhamaneshi2, Mohammad Reza Alaei3, Namam-Ali Azadi4, Rahim Vakili5, Daniel Zamanfar6, Mohammad Taghikhani1, Shohreh Khatami7.
Abstract
Methods for assaying lysosomal diseases in dried blood samples are very useful today due to its several advantages related to the stability of samples, its transportation, handled and analysis, and its potential use for newborn screening compared to traditional methods in leucocytes samples. For this reason, it is important to validate these assays before being used in routine laboratory. Because of different in biological markers based on ethnicity, we aimed this study to validation a DBS-based fluorometric assay for measurement of α-l-Iduronidase activity for diagnosis of MPS I patients in Iran. DBS samples were collected from 15 MPS I patients and 60 healthy age matched subjects. Diagnostic value, biological variance and α-l-Iduronidase activity were determined. DBS α-l-Iduronidase activity was significantly higher in male subjects than in female group. Using a cut-off level of 1.08 µmol/spot 20 h, sensitivity and specificity were 100 and 98 %. The linearity of test was proved and we showed that within-run and between run precision were 5.6 and 14.66 %. Measurement of α-l-Iduronidase activity in DBS samples is an accurate test for diagnosis of MPS I and because of its rapid shipping and simplicity to keeping, DBS-based enzyme activity could be considered as a useful diagnostic tool in this disease.Entities:
Keywords: Dried blood spot; Fluorometric test; Iran; Mucopolysaccharidosis type I; Validation; α-l-Iduronidase activity
Year: 2014 PMID: 26089619 PMCID: PMC4469054 DOI: 10.1007/s12291-014-0444-2
Source DB: PubMed Journal: Indian J Clin Biochem ISSN: 0970-1915